Cargando…

Diacritic Binding of an Indenoindole Inhibitor by CK2α Paralogs Explored by a Reliable Path to Atomic Resolution CK2α′ Structures

[Image: see text] CK2α and CK2α′ are the two isoforms of the catalytic subunit of human protein kinase CK2, an important target for cancer therapy. They have similar, albeit not identical functional and structural properties, and were occasionally reported to be inhibited with distinct efficacies by...

Descripción completa

Detalles Bibliográficos
Autores principales: Lindenblatt, Dirk, Nickelsen, Anna, Applegate, Violetta M., Hochscherf, Jennifer, Witulski, Benedict, Bouaziz, Zouhair, Marminon, Christelle, Bretner, Maria, Le Borgne, Marc, Jose, Joachim, Niefind, Karsten
Formato: Online Artículo Texto
Lenguaje:English
Publicado: American Chemical Society 2019
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6756786/
https://www.ncbi.nlm.nih.gov/pubmed/31559376
http://dx.doi.org/10.1021/acsomega.8b03415
_version_ 1783453463253876736
author Lindenblatt, Dirk
Nickelsen, Anna
Applegate, Violetta M.
Hochscherf, Jennifer
Witulski, Benedict
Bouaziz, Zouhair
Marminon, Christelle
Bretner, Maria
Le Borgne, Marc
Jose, Joachim
Niefind, Karsten
author_facet Lindenblatt, Dirk
Nickelsen, Anna
Applegate, Violetta M.
Hochscherf, Jennifer
Witulski, Benedict
Bouaziz, Zouhair
Marminon, Christelle
Bretner, Maria
Le Borgne, Marc
Jose, Joachim
Niefind, Karsten
author_sort Lindenblatt, Dirk
collection PubMed
description [Image: see text] CK2α and CK2α′ are the two isoforms of the catalytic subunit of human protein kinase CK2, an important target for cancer therapy. They have similar, albeit not identical functional and structural properties, and were occasionally reported to be inhibited with distinct efficacies by certain ATP-competitive ligands. Here, we present THN27, an indeno[1,2-b]indole derivative, as a further inhibitor with basal isoform selectivity. The selectivity disappears when measured using CK2α/CK2α′ complexes with CK2β, the regulatory CK2 subunit. Co-crystal structures of THN27 with CK2α and CK2α′ reveal that subtle differences in the conformational variability of the interdomain hinge region are correlated with the observed effect. In the case of CK2α′, a crystallographically problematic protein so far, this comparative structural analysis required the development of an experimental strategy that finally enables atomic resolution structure determinations with ab initio phasing of potentially any ATP-competitive CK2 inhibitor and possibly many non-ATP-competitive ligands as well bound to CK2α′.
format Online
Article
Text
id pubmed-6756786
institution National Center for Biotechnology Information
language English
publishDate 2019
publisher American Chemical Society
record_format MEDLINE/PubMed
spelling pubmed-67567862019-09-26 Diacritic Binding of an Indenoindole Inhibitor by CK2α Paralogs Explored by a Reliable Path to Atomic Resolution CK2α′ Structures Lindenblatt, Dirk Nickelsen, Anna Applegate, Violetta M. Hochscherf, Jennifer Witulski, Benedict Bouaziz, Zouhair Marminon, Christelle Bretner, Maria Le Borgne, Marc Jose, Joachim Niefind, Karsten ACS Omega [Image: see text] CK2α and CK2α′ are the two isoforms of the catalytic subunit of human protein kinase CK2, an important target for cancer therapy. They have similar, albeit not identical functional and structural properties, and were occasionally reported to be inhibited with distinct efficacies by certain ATP-competitive ligands. Here, we present THN27, an indeno[1,2-b]indole derivative, as a further inhibitor with basal isoform selectivity. The selectivity disappears when measured using CK2α/CK2α′ complexes with CK2β, the regulatory CK2 subunit. Co-crystal structures of THN27 with CK2α and CK2α′ reveal that subtle differences in the conformational variability of the interdomain hinge region are correlated with the observed effect. In the case of CK2α′, a crystallographically problematic protein so far, this comparative structural analysis required the development of an experimental strategy that finally enables atomic resolution structure determinations with ab initio phasing of potentially any ATP-competitive CK2 inhibitor and possibly many non-ATP-competitive ligands as well bound to CK2α′. American Chemical Society 2019-03-19 /pmc/articles/PMC6756786/ /pubmed/31559376 http://dx.doi.org/10.1021/acsomega.8b03415 Text en Copyright © 2019 American Chemical Society This is an open access article published under an ACS AuthorChoice License (http://pubs.acs.org/page/policy/authorchoice_termsofuse.html) , which permits copying and redistribution of the article or any adaptations for non-commercial purposes.
spellingShingle Lindenblatt, Dirk
Nickelsen, Anna
Applegate, Violetta M.
Hochscherf, Jennifer
Witulski, Benedict
Bouaziz, Zouhair
Marminon, Christelle
Bretner, Maria
Le Borgne, Marc
Jose, Joachim
Niefind, Karsten
Diacritic Binding of an Indenoindole Inhibitor by CK2α Paralogs Explored by a Reliable Path to Atomic Resolution CK2α′ Structures
title Diacritic Binding of an Indenoindole Inhibitor by CK2α Paralogs Explored by a Reliable Path to Atomic Resolution CK2α′ Structures
title_full Diacritic Binding of an Indenoindole Inhibitor by CK2α Paralogs Explored by a Reliable Path to Atomic Resolution CK2α′ Structures
title_fullStr Diacritic Binding of an Indenoindole Inhibitor by CK2α Paralogs Explored by a Reliable Path to Atomic Resolution CK2α′ Structures
title_full_unstemmed Diacritic Binding of an Indenoindole Inhibitor by CK2α Paralogs Explored by a Reliable Path to Atomic Resolution CK2α′ Structures
title_short Diacritic Binding of an Indenoindole Inhibitor by CK2α Paralogs Explored by a Reliable Path to Atomic Resolution CK2α′ Structures
title_sort diacritic binding of an indenoindole inhibitor by ck2α paralogs explored by a reliable path to atomic resolution ck2α′ structures
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6756786/
https://www.ncbi.nlm.nih.gov/pubmed/31559376
http://dx.doi.org/10.1021/acsomega.8b03415
work_keys_str_mv AT lindenblattdirk diacriticbindingofanindenoindoleinhibitorbyck2aparalogsexploredbyareliablepathtoatomicresolutionck2astructures
AT nickelsenanna diacriticbindingofanindenoindoleinhibitorbyck2aparalogsexploredbyareliablepathtoatomicresolutionck2astructures
AT applegateviolettam diacriticbindingofanindenoindoleinhibitorbyck2aparalogsexploredbyareliablepathtoatomicresolutionck2astructures
AT hochscherfjennifer diacriticbindingofanindenoindoleinhibitorbyck2aparalogsexploredbyareliablepathtoatomicresolutionck2astructures
AT witulskibenedict diacriticbindingofanindenoindoleinhibitorbyck2aparalogsexploredbyareliablepathtoatomicresolutionck2astructures
AT bouazizzouhair diacriticbindingofanindenoindoleinhibitorbyck2aparalogsexploredbyareliablepathtoatomicresolutionck2astructures
AT marminonchristelle diacriticbindingofanindenoindoleinhibitorbyck2aparalogsexploredbyareliablepathtoatomicresolutionck2astructures
AT bretnermaria diacriticbindingofanindenoindoleinhibitorbyck2aparalogsexploredbyareliablepathtoatomicresolutionck2astructures
AT leborgnemarc diacriticbindingofanindenoindoleinhibitorbyck2aparalogsexploredbyareliablepathtoatomicresolutionck2astructures
AT josejoachim diacriticbindingofanindenoindoleinhibitorbyck2aparalogsexploredbyareliablepathtoatomicresolutionck2astructures
AT niefindkarsten diacriticbindingofanindenoindoleinhibitorbyck2aparalogsexploredbyareliablepathtoatomicresolutionck2astructures